Summary & Overview
HCPCS S0034: Injection, ofloxacin 400 mg
HCPCS Level II code S0034 designates the injection of ofloxacin, 400 mg, used for parenteral antibiotic therapy. This billing code captures administration of a specific fluoroquinolone formulation and is relevant for outpatient and ambulatory infusion services where clinician-administered injectable antibiotics are billed separately from drug acquisition costs. Nationally, accurate coding for injectable antimicrobials matters for claims consistency, inventory management, and monitoring of utilization patterns for stewardship and cost management.
Key payers addressed in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of code definition and clinical context, payer coverage considerations, common billing modifiers, and typical sites of service. The publication also outlines benchmarks and policy-relevant items where available and highlights gaps when input data are not provided.
The coverage is intended for billing managers, practice administrators, and health policy analysts seeking a national perspective on how HCPCS Level II S0034 is used in claims, where it is most commonly applied, and what operational issues to consider when documenting and submitting claims for injectable ofloxacin, 400 mg.
Billing Code Overview
HCPCS Level II code S0034 represents an injection of ofloxacin, 400 mg. This code describes administration of the specified antibiotic formulation as an injectable medication.
Service Type: Medication administration, parenteral
Typical Site of Service: Outpatient infusion clinic, physician office, emergency department, or hospital outpatient department
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an ambulatory infusion center or emergency department with a bacterial ocular or systemic infection requiring parenteral fluoroquinolone therapy. The patient may have failed or cannot tolerate oral therapy, or the infection is severe (e.g., complicated urinary tract infection, prostatitis, or certain ocular infections). After assessment by a licensed clinician (ophthalmologist, infectious disease specialist, urologist, or emergency physician), orders are placed for parenteral S0034 (injection, ofloxacin, 400 mg). The clinical workflow includes verification of allergy history, informed consent when required, preparation of the dose by pharmacy or trained nursing staff, administration via appropriate parenteral route (typically intravenous into a peripheral or central line), monitoring for adverse reactions during and after infusion, and documentation of lot number, dose, route, time, and patient response in the medical record. For outpatient infusions, the patient is observed per facility protocol before discharge with follow-up arranged as needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no special circumstance applies and full service is rendered. |
22 | Increased procedural services | Use when administration required substantially greater effort or complexity (e.g., difficult vascular access with prolonged attempts).